This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Preexisting antiviral antibodies in cancer patients can quickly neutralize oncolytic measles virus (MV) and decrease its antitumor potency. In contrast to naked viruses, cell- associated viruses are protected from antibody neutralization," researchers in the United States report.
We care about your feedback. Let us know how we can improve your CancerCompass experience.